Copenhagen-based SNIPR Biome, a BioTech company focused on microbial CRISPR-medicine, has closed a €35 million Series B round to further CRISPR-based therapies for cystic fibrosis…
View More Danish BioTech Scale-Up SNIPR Biome Secures €35 Million to Combat Antimicrobial Resistance in Diseases Such as Cancer